Table 1.
Hematologic response to treatment with dabrafenib.
| Pretreatment | Post Cycle 3 | Post Cycle 6 | |
|---|---|---|---|
| WBC, × 103/μL | 2.7 | 4.7 | 5.9 |
| Hemoglobin, g/dL | 14.3 | 14.7 | 15.6 |
| Platelets, × 103/μL | 161 | 149 | 186 |
| Bone marrow | |||
| Cellularity (%) | 20 | 30 | 50 |
| HCL (%) | 40 | 10–15 | Zero |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.